Announcement on the Subsidiary Company Obtaining the Pharmaceutical Production License
Release time:
2021-05-20
Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: 2019-037
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Subsidiary Obtaining Drug Production License
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Recently, Anhui Zhongwang Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui Zhongwang"), a subsidiary of Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the Company"), received the "Drug Production License" issued by Anhui Drug Administration. The relevant information is hereby announced as follows:
1. Certificate Related Information
(I) Enterprise Name: anhui Zhongwang Pharmaceutical Co., Ltd.
(II) Registered Address: Anhui Dongzhe Economic Development Zone
(III) License No.: Anhui 20190419
(IV) Production Address: Anhui Dongzhe Economic Development Zone
(V) Production Scope: API
(VI) Issuing Authority: Anhui Drug Administration
(VII) Valid: 2020 12 31
2. Impact on Listed Companies and Risk Tips
This "Drug Production License" expands the scope of Anhui Zhongwang's production license, lays a foundation for Anhui Zhongwang's future production of bulk drugs, and is conducive to promoting the company's pharmaceutical industry to gradually implement the strategic upgrading of the whole industrial chain of intermediates, bulk drugs and preparations. After Anhui Zhongwang obtained the "Drug Production License" this time, it still needs to conduct the review and approval of the API, and obtain the relevant API registration number before production and sales can be carried out. The acquisition of the Pharmaceutical Production License will not have a significant impact on the Company's current operations.
Due to the industry characteristics of pharmaceutical products, the production and sales of pharmaceuticals are affected by factors such as market environment, industry policies, supply and demand, and have certain uncertainties. Please the majority of investors cautious decision-making, pay attention to prevent investment risk.
hereby announces
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
November 27, 2019
More information
Representatives of the 20th Congress preached the 20th Congress at the peak.
On the afternoon of November 11, a special lecture on the spirit of the Party's 20th Congress was held in the conference room of the Peak Building. Yang Xiayun, a representative of the 20th National Congress, walked into the peak and preached his understanding of the spirit of the 20th National Congress for Party members through personal experience.
2022
11-23
The group party committee organizes and learns the twenty spirits.
On the afternoon of October 28, the party Committee of the group organized all members to hold a special study meeting to earnestly study and understand the communique of the first plenary session of the 20th central Committee of the communist party of China and the revision of the party constitution. Jiang Xiaomeng, Secretary of the Party committee of the group, stressed at the study meeting that the 20th National Congress of the Communist Party of China has drawn a grand blueprint for building a socialist modern country in an all-round way, opened a new chapter in the era of national development, and pointed out the direction for the future development of enterprises. Party organizations at all levels of the group should pay full attention to and earnestly implement it, actively organize party members and cadres to learn the spirit of the spirit of the 20th National Congress, And to guide the future work practice.
2022
11-01
Spike Party Members and Cadres Watch the Opening Meeting of the 20th Congress
At 10 a.m. on October 16, the 20th National Congress of the Communist Party of China was solemnly opened in the Great Hall of the People in Beijing. Xi Jinping delivered a report to the Party's 20th National Congress on behalf of the 19th Central Committee. The group company attaches great importance to and carefully deploys, and organizes all party members and management backbones of the group headquarters and subsidiaries to watch the live broadcast of the opening meeting through the Internet, TV and other methods.
2022
10-23
Jiang Xiaomeng was hired as the "Shuanglong Escort" entrepreneurial mentor.
On September 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, was employed as the entrepreneurial mentor of "Shuanglong escort" at the launching ceremony of the special action of "Shuanglong escort steady progress and quality improvement" held in Jinhua City and the promotion meeting of innovative products of key talent enterprises in Jinhua City.
2022
09-27
From August 18th to 19th, the 12th Congress of the Zhejiang Federation of Industry and Commerce was held in Hangzhou, and the 12th leadership of the Provincial Federation of Industry and Commerce was elected. Jiang Xiaomeng, Secretary of the Party Committee and Chairman of the Group, was re-elected as Vice President of Zhejiang Chamber of Commerce.
2022
09-01